Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Medicines register
Registers Clinical trials Drugs API
Registers› Irish medicines ›Mundipharma Pharmaceuticals Limited
Medicines register · Ireland

Mundipharma Pharmaceuticals Limited — licensed medicines

47 medicines held by Mundipharma Pharmaceuticals Limited on the Irish market, from the HPRA register.

Download CSV
Source: HPRA open dataset ("Authorised or Transfer Pending Products"), CC BY 4.0. Complete coverage — all 10,295 authorised products are in this register. Synced 06 Oct 2026, 03:23 UTC
Narrow the register Reset
Matches brand name, active substance, licence holder and licence number.
Browse by first letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
47 of 10,295 medicines
Download
Medicine
Active substance
Licence holder
Status
Adizem-SR 120 mg Prolonged Release Capsules PA1688/001/002
Diltiazem hydrochloride
Mundipharma Pharmaceuticals Limited
Marketed
Adizem-SR 180 mg Prolonged Release Capsules PA1688/001/003
Diltiazem hydrochloride
Mundipharma Pharmaceuticals Limited
Marketed
Adizem-SR 90 mg Prolonged Release Capsules PA1688/001/001
Diltiazem hydrochloride
Mundipharma Pharmaceuticals Limited
Marketed
ADIZEM-XL 120mg prolonged release capsules PA1688/001/004
Diltiazem hydrochloride
Mundipharma Pharmaceuticals Limited
Marketed
ADIZEM-XL 180mg prolonged release capsules PA1688/001/005
Diltiazem hydrochloride
Mundipharma Pharmaceuticals Limited
Marketed
ADIZEM-XL 240 mg prolonged release capsules PA1688/001/006
Diltiazem hydrochloride
Mundipharma Pharmaceuticals Limited
Marketed
ADIZEM-XL 300 mg prolonged release capsules PA1688/001/007
Diltiazem hydrochloride
Mundipharma Pharmaceuticals Limited
Marketed
BuTrans 10 micrograms/hour transdermal patch PA1688/002/002
Buprenorphine
Mundipharma Pharmaceuticals Limited
Marketed
BuTrans 15 microgram/hour transdermal patch PA1688/002/004
Buprenorphine
Mundipharma Pharmaceuticals Limited
Marketed
BuTrans 20 micrograms/hour transdermal patch PA1688/002/003
Buprenorphine
Mundipharma Pharmaceuticals Limited
Marketed
BuTrans 5 micrograms/hour transdermal patch PA1688/002/001
Buprenorphine
Mundipharma Pharmaceuticals Limited
Marketed
Flutiform 125 microgram/5 microgram per metered dose pressurised inhalation, suspension PA1688/013/002
Fluticasone propionate, Formoterol fumarate dihydrate
Mundipharma Pharmaceuticals Limited
Marketed
Flutiform 250 microgram/10 microgram per metered dose pressurised inhalation, suspension PA1688/013/003
Fluticasone propionate, Formoterol fumarate dihydrate
Mundipharma Pharmaceuticals Limited
Marketed
Flutiform 50 microgram/5 microgram per metered dose pressurised inhalation, suspension PA1688/013/001
Fluticasone propionate, Formoterol fumarate dihydrate
Mundipharma Pharmaceuticals Limited
Marketed
MST Continus 10 mg Prolonged-release tablets PA1688/004/002
Morphine sulfate
Mundipharma Pharmaceuticals Limited
Marketed
MST Continus 100mg Prolonged-release tablets PA1688/004/006
Morphine sulfate
Mundipharma Pharmaceuticals Limited
Marketed
MST Continus 15 mg Prolonged-release tablets PA1688/004/003
Morphine sulfate
Mundipharma Pharmaceuticals Limited
Marketed
MST Continus 30 mg Prolonged-release tablets PA1688/004/004
Morphine sulfate
Mundipharma Pharmaceuticals Limited
Marketed
MST Continus 5 mg prolonged-release tablets PA1688/004/001
Morphine sulfate
Mundipharma Pharmaceuticals Limited
Marketed
OxyContin 10 mg prolonged release tablets PA1688/005/002
OXYCODONE HYDROCHLORIDE
Mundipharma Pharmaceuticals Limited
Marketed
OxyContin 20 mg prolonged release tablets PA1688/005/003
OXYCODONE HYDROCHLORIDE
Mundipharma Pharmaceuticals Limited
Marketed
OxyContin 40 mg prolonged release tablets PA1688/005/004
OXYCODONE HYDROCHLORIDE
Mundipharma Pharmaceuticals Limited
Marketed
OxyContin 5 mg prolonged release tablets PA1688/005/001
OXYCODONE HYDROCHLORIDE
Mundipharma Pharmaceuticals Limited
Marketed
OxyContin 80 mg prolonged release tablets PA1688/005/005
OXYCODONE HYDROCHLORIDE
Mundipharma Pharmaceuticals Limited
Not marketed
OxyNorm 10 mg hard capsules PA1688/006/005
OXYCODONE HYDROCHLORIDE
Mundipharma Pharmaceuticals Limited
Marketed
OxyNorm 10 mg/ml, solution for injection or infusion PA1688/006/001
OXYCODONE HYDROCHLORIDE
Mundipharma Pharmaceuticals Limited
Marketed
OxyNorm 20 mg hard capsules PA1688/006/006
OXYCODONE HYDROCHLORIDE
Mundipharma Pharmaceuticals Limited
Marketed
OxyNorm 5 mg hard capsules PA1688/006/004
OXYCODONE HYDROCHLORIDE
Mundipharma Pharmaceuticals Limited
Marketed
OxyNorm 50 mg/ml, solution for injection or infusion PA1688/006/010
OXYCODONE HYDROCHLORIDE
Mundipharma Pharmaceuticals Limited
Marketed
OxyNorm concentrate 10 mg/ml oral solution PA1688/006/003
OXYCODONE HYDROCHLORIDE
Mundipharma Pharmaceuticals Limited
Marketed
OxyNorm Dispersa 10 mg Orodispersible Tablets PA1688/006/008
OXYCODONE HYDROCHLORIDE
Mundipharma Pharmaceuticals Limited
Marketed
OxyNorm Dispersa 20 mg orodispersible tablets PA1688/006/009
OXYCODONE HYDROCHLORIDE
Mundipharma Pharmaceuticals Limited
Marketed
OxyNorm Dispersa 5 mg Orodispersible Tablets PA1688/006/007
OXYCODONE HYDROCHLORIDE
Mundipharma Pharmaceuticals Limited
Marketed
OxyNorm liquid 1 mg/ml oral solution PA1688/006/002
OXYCODONE HYDROCHLORIDE
Mundipharma Pharmaceuticals Limited
Marketed
Palladone 1.3 mg hard capsules PA1688/007/001
Hydromorphone hydrochloride
Mundipharma Pharmaceuticals Limited
Marketed
Palladone 2.6 mg hard capsules PA1688/007/002
Hydromorphone hydrochloride
Mundipharma Pharmaceuticals Limited
Not marketed
Palladone SR 2 mg prolonged release hard capsules PA1688/007/007
Hydromorphone hydrochloride
Mundipharma Pharmaceuticals Limited
Marketed
Palladone SR 4 mg prolonged release hard capsules PA1688/007/008
Hydromorphone hydrochloride
Mundipharma Pharmaceuticals Limited
Marketed
Palladone SR 8 mg prolonged release hard capsules, PA1688/007/009
Hydromorphone hydrochloride
Mundipharma Pharmaceuticals Limited
Marketed
Sevredol 10mg Film-Coated Tablets PA1688/009/001
Morphine sulfate
Mundipharma Pharmaceuticals Limited
Marketed
Sevredol 20 mg Film-Coated Tablets PA1688/009/002
Morphine sulfate
Mundipharma Pharmaceuticals Limited
Marketed
Targin 10mg/5mg prolonged-release tablets PA1688/010/002
OXYCODONE HYDROCHLORIDE, Naloxone hydrochloride dihydrate
Mundipharma Pharmaceuticals Limited
Marketed
Targin 15 mg/7.5 mg prolonged-release tablets PA1688/010/006
OXYCODONE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE
Mundipharma Pharmaceuticals Limited
Marketed
Targin 20mg/10mg prolonged-release tablets PA1688/010/003
OXYCODONE HYDROCHLORIDE, Naloxone hydrochloride dihydrate
Mundipharma Pharmaceuticals Limited
Marketed
Targin 30 mg/15 mg prolonged-release tablets PA1688/010/007
OXYCODONE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE
Mundipharma Pharmaceuticals Limited
Marketed
Targin 40 mg/20 mg prolonged-release tablets PA1688/010/004
OXYCODONE HYDROCHLORIDE, Naloxone hydrochloride dihydrate
Mundipharma Pharmaceuticals Limited
Marketed
Targin 5 mg/2.5 mg prolonged-release tablets PA1688/010/001
OXYCODONE HYDROCHLORIDE, Naloxone hydrochloride dihydrate
Mundipharma Pharmaceuticals Limited
Marketed
Showing 1–47 of 47
1
Cite this view

Priya Life Science (2026). Irish Medicines Register, filtered. Derived from the HPRA open dataset. Retrieved 6 October 2026. https://priyalifescience.com/medicines/company/mundipharma-pharmaceuticals-limited

Download this register
GET /api/export.php?register=medicines-ie&format=csv Try the JSON export →
Regulatory information only — not medical advice. For the authoritative record see the HPRA register directly.